:线

Hua-Qing Niu1, Bo-Yv Zheng2, Ming-Xiang Zou3

  • 1Department of Ophthalmology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, China.

概括

科尔多马的免疫微环境是免疫排除的,而不是"热". 较高的免疫透率,T淋巴细胞得分和HLA-I表达与较差的冠状瘤预后相关,这表明T细胞免疫疗法的有效性有限.